These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 20853093)

  • 21. [Blood - surely but safely!].
    Offergeld R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Aug; 55(8):905-6. PubMed ID: 22842882
    [No Abstract]   [Full Text] [Related]  

  • 22. Modeling the risk of an emerging pathogen entering the Canadian blood supply.
    Kleinman S; Cameron C; Custer B; Busch M; Katz L; Kralj B; Matheson I; Murphy K; Preiksaitis J; Devine D
    Transfusion; 2010 Dec; 50(12):2592-606. PubMed ID: 20553433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Blood safety in Mexico. Achievements and challenges].
    Sánchez-Guerrero SA
    Rev Invest Clin; 2011; 63(3):309-13. PubMed ID: 21888294
    [No Abstract]   [Full Text] [Related]  

  • 24. The safety and availability of blood and tissues--progress and challenges.
    Goodman JL
    N Engl J Med; 2004 Aug; 351(8):819-22. PubMed ID: 15317896
    [No Abstract]   [Full Text] [Related]  

  • 25. Detection of poxvirus in cattle associated with human cases in the State of Rio de Janeiro: preliminary report.
    Schatzmayr HG; Lemos ER; Mazur C; Schubach A; Majerowicz S; Rozental T; Schubach TM; Bustamante MC; Barth OM
    Mem Inst Oswaldo Cruz; 2000; 95(5):625-7. PubMed ID: 10998211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid Viral Diagnosis of Orthopoxviruses by Electron Microscopy: Optional or a Must?
    Gelderblom HR; Madeley D
    Viruses; 2018 Mar; 10(4):. PubMed ID: 29565285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emerging viruses and transfusion.
    Allain JP
    Transfus Clin Biol; 2001 Jun; 8(3):220-1. PubMed ID: 11499963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation and Characterization of Akhmeta Virus from Wild-Caught Rodents (
    Doty JB; Maghlakelidze G; Sikharulidze I; Tu SL; Morgan CN; Mauldin MR; Parkadze O; Kartskhia N; Turmanidze M; Matheny AM; Davidson W; Tang S; Gao J; Li Y; Upton C; Carroll DS; Emerson GL; Nakazawa Y
    J Virol; 2019 Dec; 93(24):. PubMed ID: 31554682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of Borna disease virus RNA in populations at high or low risk for blood-borne infections.
    Lefrère JJ; Mariotti M; Laperche S; Brossard Y; Girot R; Lefrère F
    Transfusion; 2004 Sep; 44(9):1396. PubMed ID: 15318870
    [No Abstract]   [Full Text] [Related]  

  • 30. Animal models of orthopoxvirus infection.
    Chapman JL; Nichols DK; Martinez MJ; Raymond JW
    Vet Pathol; 2010 Sep; 47(5):852-70. PubMed ID: 20682806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood-Borne Pathogens: A Canadian Blood Services Centre for Innovation Symposium.
    Walsh GM; Shih AW; Solh Z; Golder M; Schubert P; Fearon M; Sheffield WP
    Transfus Med Rev; 2016 Apr; 30(2):53-68. PubMed ID: 26962008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transfusion safety: Where are we today?
    Luban NL
    Ann N Y Acad Sci; 2005; 1054():325-41. PubMed ID: 16339681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood safety--at what cost?
    Bekker LG; Wood R
    JAMA; 2006 Feb; 295(5):557-8. PubMed ID: 16449622
    [No Abstract]   [Full Text] [Related]  

  • 34. Emerging pathogens and their implications for the blood supply and transfusion transmitted infections.
    Dodd RY
    Br J Haematol; 2012 Oct; 159(2):135-42. PubMed ID: 22924410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The potential of viral metagenomics in blood transfusion safety.
    Sauvage V; Gomez J; Boizeau L; Laperche S
    Transfus Clin Biol; 2017 Sep; 24(3):218-222. PubMed ID: 28694025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in pretransfusion infectious disease testing: ensuring the safety of transfusion therapy.
    Downes KA; Yomtovian R
    Clin Lab Med; 2002 Jun; 22(2):475-90. PubMed ID: 12134472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging, re-emerging and submerging infectious threats to the blood supply.
    Alter HJ
    Vox Sang; 2004 Jul; 87 Suppl 2():56-61. PubMed ID: 15209880
    [No Abstract]   [Full Text] [Related]  

  • 38. Human and animal infections by vaccinia-like viruses in the state of Rio de Janeiro: a novel expanding zoonosis.
    Schatzmayr HG; Costa RV; Gonçalves MC; D'Andréa PS; Barth OM
    Vaccine; 2011 Dec; 29 Suppl 4():D65-9. PubMed ID: 22185829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The risk of substitution therapy with blood and blood products].
    Baumgarten R
    Z Arztl Fortbild (Jena); 1994 Jan; 88(1):3-4. PubMed ID: 8154136
    [No Abstract]   [Full Text] [Related]  

  • 40. Status of NAT screening for HCV, HIV and HBV--experiences of the German Red Cross Blood Donation Services.
    Seifried E; Findhammer S; Roth WK
    Dev Biol (Basel); 2002; 108():23-7. PubMed ID: 12220139
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.